Chenghao Zhao
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Low-dose bevacizumab plus atezolizumab enhances transarterial chemoembolization in HCC via correcting vascular-immune niche dysfunction.
Journal: Journal of hepatology
Published: February 09, 2026
Development and validation of a simplified dynamic nomogram for preoperative prediction of microvascular invasion in hepatocellular carcinoma.
Journal: European journal of gastroenterology & hepatology
Published: November 18, 2025
Low-dose chemotherapy remodels hepatic immune landscape and potentiates anti-tumor response to immune checkpoint blockade in cholangiocarcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: November 01, 2025
Transfemoral approach TACE technique in orthotopic PDX hepatocellular carcinoma models of nude rats.
Transfemoral approach TACE technique in orthotopic PDX hepatocellular carcinoma models of nude rats.
Journal: Quantitative imaging in medicine and surgery
Published: May 28, 2025
TACE Sequential to Radiofrequency Ablation versus RFA Alone in Hepatocellular Carcinoma Within Milan Criteria.
Journal: Journal of hepatocellular carcinoma
Published: May 14, 2025
Lenvatinib continuation versus regorafenib in treating hepatocellular carcinoma after lenvatinib failure.
Journal: Quantitative imaging in medicine and surgery
Published: March 10, 2025
Donafenib vs. lenvatinib combined with transarterial chemoembolization as initial therapy for unresectable hepatocellular carcinoma: a retrospective real-world study.
Journal: Quantitative imaging in medicine and surgery
Published: February 13, 2025
Clinical Effectiveness of Drug-Eluting Microsphere Transcatheter Arterial Chemoembolization Combined with First-Line Chemotherapy as the Initial Treatment for Patients with Unresectable Intrahepatic Cholangiocarcinoma.
Journal: Journal of vascular and interventional radiology : JVIR
Published: August 03, 2023
Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab or Lenvatinib for Unresectable Hepatocellular Carcinoma: A Propensity Score Matched Study.
Journal: Journal of hepatocellular carcinoma
Published: May 04, 2023
Idarubicin versus epirubicin in drug-eluting beads-transarterial chemoembolization for treating hepatocellular carcinoma: A real-world retrospective study.
Journal: Investigational new drugs
Published: May 01, 2023
Long-term Outcomes of Patients with Hepatocellular Carcinoma Who Underwent Microwave Ablation after Downstaging with Transarterial Chemoembolization to Barcelona Clinic Liver Cancer Stage A.
Journal: Journal of vascular and interventional radiology : JVIR
Published: December 14, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026